Eosinophil activity markers in peripheral blood have high predictive value for bronchial hyperreactivity in patients with suspected mild asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 7, 1996, Pages 482-488

  Roquet, A ^a   Hallden G ^b   Ihre, E ^a   Hed, J ^a   Zetterstrom O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Thermo Fisher Scientific   (United States)

Author keywords

Asthma; Bronchial hyperreactivity; EG2; Eosinophil activity markers; Predictive value; Serum eosinophil cationic protein

Indexed keywords

ADULT; ARTICLE; ASTHMA; BRONCHUS REACTIVITY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EOSINOPHIL; FEMALE; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL;

EID: 0030035416     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb00165.x     Document Type: Article

References (23)

1. Smith L. Does refining the histamine bronchoprovocation test improve our ability to diagnose asthma? Ann Allergy 1994;73:l-3.
2. Horn B, Robin E, Teodore J, van Kessel A. Total eosinophilia counts in the management of bronchial asthma. N Engl J Med 1975;292:1152-5.
3. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993;147:669-704.
4. Lowell F. Clinical aspects of eosinophilia in atopic disease. JAMA 1967;202:875-8.
5. Dahl R, Venge P, Olsson I. Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Allergy 1978;33:211-15.
6. Ferguson A, Vaughan R, Brown H, Curtis C. Evaluation of serum eosinophil cationic protein as a marker of disease activity in chronic asthma. J Allergy Clin Immunol 1995;95:23-8.
7. Ihre E, Skedinger M, Halldén G, Hed J, Lagerstrand L, Zetterström O. Clinical symptoms and changes in eosinophil activity in peripheral blood in allergic asthmatic patients during a pollen season. In: Ihre E, editor. Physiological changes and eosinophil activation in allergen induced asthma. Thesis, Karolinska Institute, Stockholm, 1993.
8. Durham SR, Loegering A, Dunnette S, Gleich GJ, Kay AB. Blood eosinophils and eosinophil-derived proteins in allergic asthma. J Allergy Clin Immunol 1989;84:931-6.
9. Tai P-C, Spry C, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature 1984;309:182-4.
10. Halldén G, Hed J. The FOG-method - a new approach to detecting activated eosinophils. Allergy Clin Immunol News 1993;5:139.
11. Hed J, Halldén G. Counts of activated blood eosinophils for monitoring asthma. Allergy 1993;48 Suppl 17: 87-93.
12. Skedinger M, Halldén G, Lundahl J, Hed J, Zetterström O. Eosinophil activity reflects clinical status in patients with asthma before and during a prednisolone course. Ann Allergy Asthma Immunol 1995;95:23-8.
13. Carlsson M, Hâkansson L, Peterson C, Stâlenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
14. Lacoste J-Y, Bousquet J, Chanez P, et al. Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease. J Allergy Clin Immunol 1993;92:537-48.
15. Taylor K, Luksza K. Peripheral blood eosinophil counts and bronchial responsiveness. Thorax 1987;42:452-6.
16. Halldén G, Andersson U, Hed J, Johansson S. A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry. J Immunol Methods 1989;124:103-9.
17. Nieminen MM, Holli H, Lahdensuo A, Muttari A, Karvonen J. Aerosol deposition in automatic dosimeter nebulization. Eur J Respir Dis 1987;71:145-52.
18. Bousquet J, Chanez P, Lacoste J. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-9.
19. Dahl R, Venge P, Fredens K. Eosinophils. In: Barnes PJ, Rodger I\V, Thomson NC, editors. Asthma: basic mechanisms and clinical management. London: Academic Press, 1992:111-21.
20. de Monchy J, Kauffman H, Venge P, Koeter GEA. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985;131: 373-6.
21. Frigas E, Loegering DA, SoIIey GO, Farrow GM, Gleich GJ. Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981;56:345-53.
22. Roquet A, Ihre E, van Hage-Hamsten M, Halldén G, Zetterström O. Allergen-induced inflammation in the nose. A Comparison of acute and repeated low-dose allergen exposures. Allergy 1996;51:42-8.
23. Ihre E, Halldén G, Hed J, Zetterström O. Change in eosinophil expression of ECP and its relation to bronchial responsiveness after repeated inhalation of low doses of allergen. In: Ihre E, editor. Physiological changes and eosinophil activation in allergen induced asthma. Thesis, Karolinska Institute, Stockholm, 1993.